
Forte Biosciences (FBRX) P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.87
Average-0.7010
Median-0.6900
Minimum-0.9100
Maximum-0.5100
-0.87
Past Month-0.32 (58.18%)
The P/E ratio for Forte Biosciences (FBRX) is -0.87 as of Jun 13, 2025. This represents a increase of 42.62% compared to its 12-month average P/E ratio of -0.61. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Forte Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Forte Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Forte Biosciences to industry peers.
Forte Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Forte Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Forte Biosciences to industry peers.
Forte Biosciences (FBRX) P/E Ratio Insights
See Forte Biosciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Forte Biosciences (FBRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Forte Biosciences (FBRX) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $8.83 | -0.64 |
May 1, 2025 | $7.163 | -0.44 |
Apr 1, 2025 | $7.43 | -0.45 |
Mar 3, 2025 | $7.68 | -0.40 |
Feb 3, 2025 | $14.97 | -0.77 |
Jan 2, 2025 | $25.27 | -1.30 |
Forte Biosciences (FBRX) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.87 | -25.64% |
2024 | -1.17 | +77.27% |
2023 | -0.66 | -48.03% |
2022 | -1.27 | -7.30% |
2021 | -1.37 | -36.87% |
2020 | -2.17 | — |
FAQs About Forte Biosciences (FBRX) P/E ratio
The latest P/E ratio of Forte Biosciences (FBRX) is -0.87, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Forte Biosciences’s last 12-month average P/E ratio is -0.61, compared to its current P/E ratio of -0.87. This reflects a increase of 42.62%.
Forte Biosciences’s current P/E ratio of -0.87 is higher than its last 12-month average P/E of -0.61. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Forte Biosciences’s average P/E ratio over the last 3 years is -0.81. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Forte Biosciences’s average P/E ratio over the last 5 years is -2.05. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.